Comparing biomarkers for COVID-19 disease with commonly associated preexisting conditions and complications
View ORCID ProfileJesse Huang
doi: https://doi.org/10.1101/2020.10.02.20205609
Jesse Huang
1Kii Research Institute, Vancouver, Washington, USA
2Center of Molecular Medicine, Department of Clinical Neuroscience, Karolinska University Hospital, Karolinska Institutet, SE-171 77 Stockholm, Sweden

- Supplementary Material[supplements/205609_file02.xlsx]
Posted October 05, 2020.
Comparing biomarkers for COVID-19 disease with commonly associated preexisting conditions and complications
Jesse Huang
medRxiv 2020.10.02.20205609; doi: https://doi.org/10.1101/2020.10.02.20205609
Subject Area
Subject Areas
- Addiction Medicine (412)
- Allergy and Immunology (726)
- Anesthesia (214)
- Cardiovascular Medicine (3115)
- Dermatology (263)
- Emergency Medicine (463)
- Epidemiology (13058)
- Forensic Medicine (13)
- Gastroenterology (864)
- Genetic and Genomic Medicine (4877)
- Geriatric Medicine (449)
- Health Economics (752)
- Health Informatics (3077)
- Health Policy (1109)
- Hematology (410)
- HIV/AIDS (968)
- Medical Education (455)
- Medical Ethics (121)
- Nephrology (502)
- Neurology (4651)
- Nursing (247)
- Nutrition (689)
- Oncology (2398)
- Ophthalmology (681)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (308)
- Palliative Medicine (88)
- Pathology (517)
- Pediatrics (1244)
- Primary Care Research (522)
- Public and Global Health (7210)
- Radiology and Imaging (1607)
- Respiratory Medicine (944)
- Rheumatology (461)
- Sports Medicine (403)
- Surgery (515)
- Toxicology (65)
- Transplantation (222)
- Urology (191)